Osaic Holdings
CTSO icon

Osaic Holdings’s Cytosorbents Corp CTSO Stock Holding History

Osaic Holdings’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50K Buy
6,742
+221
+3% +$2.33K ﹤0.01% 5493
2026
Q1 		$74.2K Hold
6,521
– – ﹤0.01% 4902
2025
Q4 		$83.4K Hold
6,521
– – ﹤0.01% 4857
2025
Q3 		$122K Hold
6,521
– – ﹤0.01% 4619
2025
Q2 		$167K Sell
6,521
-1,666
-20% -$33.5K ﹤0.01% 4094
2025
Q1 		$164K Buy
8,187
+1,826
+29% +$38.5K ﹤0.01% 3794
2024
Q4 		$116K Buy
6,361
+240
+4% +$4.71K ﹤0.01% 4066
2024
Q3 		$184K Buy
6,121
+500
+9% +$11K ﹤0.01% 3719
2024
Q2 		$78.8K Sell
5,621
-70
-1% -$1.21K ﹤0.01% 4325
2024
Q1 		$108K Buy
5,691
+55
+1% +$1.07K ﹤0.01% 4188
2023
Q4 		$125K Sell
5,636
-3,628
-39% -$108K ﹤0.01% 4270
2023
Q3 		$348K Buy
9,264
+5,344
+136% +$307K ﹤0.01% 3557
2023
Q2 		$281K Buy
3,920
+7
+0.2% +$443 ﹤0.01% 3626
2023
Q1 		$264K Buy
3,913
+127
+3% +$7.62K ﹤0.01% 3648
2022
Q4 		$118K Buy
3,786
+48
+1% +$1.42K ﹤0.01% 4301
2022
Q3 		$101K Sell
3,738
-55
-1% -$2.15K ﹤0.01% 4368
2022
Q2 		$166K Buy
3,793
+46
+1% +$2.11K ﹤0.01% 3966
2022
Q1 		$1.54M Buy
3,747
+9
+0.2% +$645 ﹤0.01% 2159
2021
Q4 		$314K Sell
3,738
-90
-2% -$10.1K ﹤0.01% 3517
2021
Q3 		$623K Sell
3,828
-60
-2% -$9.75K ﹤0.01% 2810
2021
Q2 		$588K Buy
3,888
+210
+6% +$35.4K ﹤0.01% 2846
2021
Q1 		$639K Sell
3,678
-42
-1% -$8.01K ﹤0.01% 2627
2020
Q4 		$594K Buy
3,720
+1,019
+38% +$171K ﹤0.01% 2487
2020
Q3 		$431K Buy
2,701
+773
+40% +$139K ﹤0.01% 2564
2020
Q2 		$382K Sell
1,928
-271
-12% -$49.8K ﹤0.01% 2569
2020
Q1 		$281K Buy
+2,199
New +$222K ﹤0.01% 2581

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's CTSO Position: Q2 2026 in Review

Osaic Holdings increased its Cytosorbents Corp (CTSO) stake by 3.4% in Q2 2026, buying an estimated $2.33K and bringing the position to 6,742 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #5493.

Osaic Holdings first reported a position in CTSO in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.54M in Q1 2022. 47 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Osaic Holdings held 6,742 shares of Cytosorbents Corp worth $50K as of Q2 2026.
  • Osaic Holdings bought 221 Cytosorbents Corp shares in Q2 2026, an estimated $2.33K.
  • Cytosorbents Corp made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5493 holding.
  • Osaic Holdings first reported a position in Cytosorbents Corp in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Cytosorbents Corp position peaked at $1.54M in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.